跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 60,380 条关于
“checkpoint inhibitor-relapsed tumors”
全部
60,380
临床试验
44,495
药物
4,578
机构
82
资讯
11,225
11个月前
Phase 1/2 Trial Shows Promise for Gut Microbiome Therapy Combined with Immunotherapy in Advanced Cancers
去年
Invikafusp Alfa Demonstrates Promising Activity in Immune Checkpoint Inhibitor-Resistant Solid Tumors
去年
HPK1 Inhibitors Show Promise in Enhancing Immunotherapy for Solid Tumors
去年
Vetigenics Initiates First Dual Immune Checkpoint Inhibitor Trial in Dogs with Solid Tumors
11个月前
Invikafusp Alfa Shows Promise in Checkpoint Inhibitor-Resistant Solid Tumors with High Disease Control Rates
去年
Pheast Therapeutics Initiates Phase 1 Trial of Novel Anti-CD24 Macrophage Checkpoint Inhibitor for Advanced Solid Tumors
2年前
GV20 Therapeutics Reports First Clinical Data for AI-Designed Checkpoint Inhibitor GV20-0251 in Advanced Solid Tumors
2个月前
Coherus and Zumutor Launch Phase 1 Trial of NK Checkpoint Antibody ZM008 Combined with PD-1 Inhibitor LOQTORZI in Solid Tumors
8个月前
Ruxolitinib Combination Therapy Shows Promise in Checkpoint Inhibitor-Resistant Hodgkin Lymphoma
2年前
Zynyz Plus Chemotherapy Shows Promise in Advanced Anal Cancer
第 1 页，共 1123 页
上一页
下一页
